Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
CEO: Guillermo Novo. Company website
Ashland Inc. (ASH) trades at $69.06, down 1.02% on the day, as of Sep 20, 2026 14:58 UTC.
Ashland Inc. has a market capitalisation of $3.16B, calculated from the live ASH share price and shares outstanding.
ASH trades at a trailing P/E of 61.12, from earnings per share of $1.13 over the last twelve months.
Ashland Inc. generated revenue of $1.84B over the trailing twelve months, which puts the stock at 1.72 times sales.
Yes. Ashland Inc. pays a dividend yielding 2.55% on the current share price.
ASH has traded between $46.30 and $78.25 over the past 52 weeks, and the last price is 11.7% below that high.
Yes. Ashland Inc. keeps 2.82% of revenue as net income over the trailing twelve months.
Wall Street analysts rate ASH Buy, with an average price target of $78.71, 14.0% above the current price.
Ashland Inc. is classified under the Basic Materials sector and the Chemicals - Specialty industry, and is domiciled in US.
Guillermo Novo is the chief executive of Ashland Inc., which employs 2,900 people.
QFI Terminal shows ASH with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open ASH in Terminal See plans